Trend tracking and harm reduction policies may help alleviate the high rate of overdose deaths in the US, according to one ...

Doctors conducted suicide risk assessments for 42% of patients flagged by interruptive alerts, compared with only 4% with ...

Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...

Study highlights barriers to care, treatment preferences, and interest in research participation in psoriasis in the Latine ...

Quality-of-life (QOL) outcomes vary widely for patients receiving first-line treatment for chronic lymphocytic leukemia (CLL) ...

Sexual counseling and education based on self-efficacy theory improved sexual function in women with breast cancer, enhancing ...

The rates at which ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thin in the eyes was ...

With high biologic treatment failure rates common among patients who have hidradenitis suppurativa (HS), investigators set ...

Record numbers have enrolled in Affordable Care Act (ACA) coverage as open enrollment continues through January 15, 2025.

Nurse-led care effectively reduces disease activity and improves self-efficacy in patients with rheumatoid arthritis, ...

For several years, investigators have been studying combinations that include ruxolitinib, sold as Jakafi, to treat ...

Panelists discuss how managing alopecia areata (AA) involves multiple health care specialties, including dermatology and mental health, and how multidisciplinary care can be optimized, while also ...